Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
According to our (Global Info Research) latest study, the global Testosterone Replacement Therapy market size was valued at USD 1570.7 million in 2022 and is forecast to a readjusted size of USD 1186.9 million by 2029 with a CAGR of -3.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For more information (Including Full TOC, List of Tables & Figures, Chart), please click @ https://www.globalinforesearch.com/reports/1003425/testosterone-replacement-therapy
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
This report is a detailed and comprehensive analysis for global Testosterone Replacement Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Market segment by Type
Gels
Injections
Patches
Other
Market segment by Application
Hospitals
Clinics
Others
Major players covered
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Testosterone Replacement Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Testosterone Replacement Therapy, with price, sales, revenue and global market share of Testosterone Replacement Therapy from 2018 to 2023.
Chapter 3, the Testosterone Replacement Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Testosterone Replacement Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Testosterone Replacement Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Testosterone Replacement Therapy.
Chapter 14 and 15, to describe Testosterone Replacement Therapy sales channel, distributors, customers, research findings and conclusion.
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-17665052062 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
